Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
O S Nielsen, P Reichardt, T B Christensen, et al.
Bone Marrow Transplantation
|
September 11, 1998
The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue
B C Millar, J L Millar, V Shepherd, et al.
Cancer Chemotherapy and Pharmacology
|
February 22, 2002
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation
D Fyfe, F Raynaud, R E Langley, et al.
British Journal of Cancer
|
April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
S Postel-Vinay, H-T Arkenau, D Olmos, et al.
Lancet (London, England)
|
January 2, 1982
Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia
J G Watson, B Jameson, R L Powles, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
M Schlemmer, P Reichardt, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours
J-Y Blay, A Le Cesne, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2018
Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database study
A J Verschoor, S Litière, S Marréaud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
A T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2011
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
H-T Arkenau, R Plummer, L R Molife, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
O S Nielsen, P Reichardt, T B Christensen, et al.
Bone Marrow Transplantation
|
September 11, 1998
The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue
B C Millar, J L Millar, V Shepherd, et al.
Cancer Chemotherapy and Pharmacology
|
February 22, 2002
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation
D Fyfe, F Raynaud, R E Langley, et al.
British Journal of Cancer
|
April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
S Postel-Vinay, H-T Arkenau, D Olmos, et al.
Lancet (London, England)
|
January 2, 1982
Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia
J G Watson, B Jameson, R L Powles, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
M Schlemmer, P Reichardt, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours
J-Y Blay, A Le Cesne, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2018
Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database study
A J Verschoor, S Litière, S Marréaud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
A T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2011
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
H-T Arkenau, R Plummer, L R Molife, et al.
Page
of 12